GHK-Cu is a natural copper-binding tripeptide (Gly-His-Lys) first found in human blood
In their separate Phase 2 trials, retatrutide monotherapy showed larger weight loss (~24.2% at 48 weeks, 12 mg) than standalone cagrilintide (~10.8% at 26 weeks, 4.5 mg), and indirect network meta-analyses rank retatrutide highly
Our Physician Medical Weight Loss Training course is CME-accredited and covers GLP-1 protocols, lipotropic and B12 injection technique and dosing, patient selection, comorbidity screening, and the program design that makes any of it work
Endothelial senescence (2025, PMC) Reported FOXO4-DRI clearing senescent endothelial cells via a p53/BCL-2/caspase-3 pathway in animal and cell models
treat it as one, keep the weekly interval consistent, and direct your attention to the factors that the evidence shows actually determine the outcome